Lévy Yves
Service d'immunologie Clinique, Hopital Henri Mondor, 51 Avenue du Marechal de Lattre de Tassigny, 94010 Creteil, France.
Curr HIV/AIDS Rep. 2005 Feb;2(1):5-9. doi: 10.1007/s11904-996-0002-5.
The goal of therapeutic immunization in HIV infection is to induce strong and sustained immune responses against HIV. Several arguments suggest that the immune system may contain HIV replication in the long term before declining. The potency on new antiviral regimens in clinic has provided an opportunity to improve the control of the virus replication by the immune system. In clinical terms, this might allow patients to delay or to stop antiviral therapy and to minimize the duration of the exposition to antiviral drugs.
HIV感染治疗性免疫的目标是诱导针对HIV的强烈且持续的免疫反应。有几个论据表明,免疫系统可能在长期内抑制HIV复制,直至其功能衰退。临床中新抗病毒方案的效力为通过免疫系统改善病毒复制控制提供了契机。从临床角度来看,这或许能使患者推迟或停止抗病毒治疗,并尽量缩短接触抗病毒药物的时间。